title: Myocardial Protection During Cardiotoxic Chemotherapy.
authors.affiliation: From Division of Cardiovascular Medicine, Stanford University School of Medicine, CA (R.M.W.); Cardiology Department, Cardiovascular Institute, Hospital Clinic, Barcelona, Spain (X.B.); and Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Spain (X.B.).
authors.forename: Ronald M
authors.initials: RM
authors.lastname: Witteles
authors.affiliation: From Division of Cardiovascular Medicine, Stanford University School of Medicine, CA (R.M.W.); Cardiology Department, Cardiovascular Institute, Hospital Clinic, Barcelona, Spain (X.B.); and Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Spain (X.B.). xbosch@clinic.ub.es.
authors.forename: Xavier
authors.initials: X
authors.lastname: Bosch
mesh_terms: D000818:Animals; D018943:Anthracyclines / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D066126:Cardiotoxicity / Q000175:diagnosis / Q000517:prevention & control*; D006331:Heart Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control*; D006801:Humans
chemical_list: D018943:Anthracyclines; D000970:Antineoplastic Agents; D002316:Cardiotonic Agents
keywords: cardiotoxicity; cardiovascular diseases; complications; drug therapy; neoplasms; prevention